+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Psoriatic Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Uveitis - Pipeline Insight, 2025 - Product Thumbnail Image

Uveitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alopecia - Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lambert-Eaton Myasthenic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Lambert-Eaton Myasthenic Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2025 - Product Thumbnail Image

Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Androgenetic Alopecia - Pipeline Insight, 2025 - Product Thumbnail Image

Androgenetic Alopecia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Alopecia Areata- Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia Areata- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Allergic Rhinitis - Pipeline Insight, 2025 - Product Thumbnail Image

Allergic Rhinitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis III - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis III - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Systemic Lupus Erythematosus - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
CRF1 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

CRF1 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bradykinin Receptor B2 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Bradykinin Receptor B2 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bradykinin Receptor B1 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Bradykinin Receptor B1 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Prostaglandin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Prostaglandin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
P2X7 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

P2X7 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Toll-like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more